This announcement is a separate document:
クリングルファーマ：ALSなどの中枢神経疾患に対するHGF治療薬の開発に関する総説が機関誌「ファルマシア」に掲載されました
KRINGLE PHARMA: A review article on the development of HGF therapeutics for central nervous system diseases such as ALS was published in the journal “Pharmacia”
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.